phenytoin sodium
Generic: phenytoin sodium
Labeler: major pharmaceuticalsDrug Facts
Product Profile
Brand Name
phenytoin sodium
Generic Name
phenytoin sodium
Labeler
major pharmaceuticals
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
phenytoin sodium 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0904-7416
Product ID
0904-7416_46d5c0d1-a97b-46d9-8cf4-994780673337
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040684
Listing Expiration
2026-12-31
Marketing Start
2025-12-09
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
09047416
Hyphenated Format
0904-7416
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
phenytoin sodium (source: ndc)
Generic Name
phenytoin sodium (source: ndc)
Application Number
ANDA040684 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 100 BLISTER PACK in 1 CARTON (0904-7416-61) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46d5c0d1-a97b-46d9-8cf4-994780673337", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["46d5c0d1-a97b-46d9-8cf4-994780673337"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-7416-61) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0904-7416-61", "marketing_start_date": "20251209"}], "brand_name": "Phenytoin Sodium", "product_id": "0904-7416_46d5c0d1-a97b-46d9-8cf4-994780673337", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0904-7416", "generic_name": "Phenytoin Sodium", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20251209", "listing_expiration_date": "20261231"}